64 research outputs found
Overview of the Experimental Physics and Industrial Control System (EPICS) Channel Archiver
The Channel Archiver has been operational for more than two years at Los
Alamos National Laboratory and other sites. This paper introduces the available
components (data sampling engine, viewers, scripting interface, HTTP/CGI
integration and data management), presents updated performance measurements and
reviews operational experience with the Channel Archiver.Comment: 3 pages, 1 figure, 8th International Conference on Accelerator and
Large Experimental Physics Control Systems (PSN THAP019), San Jose, CA, USA,
November 27-3
Integrating LabVIEW into a Distributed Computing Environment
Being easy to learn and well suited for a self-contained desktop laboratory
setup, many casual programmers prefer to use the National Instruments LabVIEW
environment to develop their logic. An ActiveX interface is presented that
allows integration into a plant-wide distributed environment based on the
Experimental Physics and Industrial Control System (EPICS). This paper
discusses the design decisions and provides performance information, especially
considering requirements for the Spallation Neutron Source (SNS) diagnostics
system.Comment: 3 pages, 2 figures, 8th International Conference on Accelerator and
Large Experimental Physics Control Systems (PSN THAP032), San Jose, CA, USA,
November 27-3
The EPICS Software Framework Moves from Controls to Physics
The Experimental Physics and Industrial Control System (EPICS), is an open-source software framework for high-performance distributed control, and is at the heart of many of the world’s large accelerators and telescopes. Recently, EPICS has undergone a major revision, with the aim of better computing supporting for the next generation of machines and analytical tools. Many new data types, such as matrices, tables, images, and statistical descriptions, plus users’ own data types, now supplement the simple scalar and waveform types of the former EPICS. New computational architectures for scientific computing have been added for high-performance data processing services and pipelining. Python and Java bindings have enabled powerful new user interfaces. The result has been that controls are now being integrated with modelling and simulation, machine learning, enterprise databases, and experiment DAQs. We introduce this new EPICS (version 7) from the perspective of accelerator physics and review early adoption cases in accelerators around the world
Recommended from our members
Ground test accelerator control system software
The GTA control system provides an environment in which the automation of a state-of-the-art accelerator can be developed. It makes use of commercially available computers, workstations, computer networks, industrial I/O equipment, and software. This system has built-in supervisory control (like most accelerator control systems), tools to support continuous control (like the process control industry), and sequential control for automatic startup and fault recovery (like few other accelerator control systems). Several software tools support these levels of control: a real-time operating system (VxWorks) with a real-time kernel (VRTX), a configuration database, a sequencer, and a graphics editor. VxWorks supports multitasking, fast context-switching, and preemptive scheduling. VxWorks/VRTX is a network-based development environment specifically designed to work in partnership with the UNIX operating system. A database provides the interface to the accelerator components. It consists of a run time library and a database configuration and editing tool. A sequencer initiates and controls the operation of all sequence programs (expressed as state programs). A graphics editor gives the user the ability to create color graphic displays showing the state of the machine in either text or graphics form. 11 refs., 2 figs
Diffuse large B-cell non-Hodgkin lymphomas: the clinical relevance of histological subclassification
In the REAL classification the diffuse large B-cell non-Hodgkin lymphomas (NHL) are grouped together, because subclassifications are considered to lack both reproducibility and clinical significance. Others, however, claim that patients with an immunoblastic NHL have a worse prognosis than patients with other types of diffuse large B-cell NHL. Therefore, we investigated the prognostic and clinical significance of histological subclassification of diffuse large B-cell NHL in a uniformly treated series of patients. For this retrospective study, all patients diagnosed as having an immunoblastic (IB) B-cell NHL by the Lymphoma Review Panel of the Comprehensive Cancer Center Amsterdam (CCCA) between 1984 and 1994, and treated according to the guidelines of the CCCA, were analysed. Patients with a centroblastic polymorphic subtype (CB-Poly) or centroblastic (CB) NHL by the Lymphoma Review Panel who were treated in the Netherlands Cancer Institute during the same period according to CCCA guidelines were used as reference groups. All patients' records were reviewed. Clinical parameters at presentation, kind of therapy and clinical outcome were recorded. All available histological slides were separately reviewed by two haemato-pathologists. One hundred and seventy-seven patients were included in the study: 36 patients (20.3%) with an IB NHL, 69 patients (39%) with a CB-Poly NHL and 72 patients (40.7%) with a CB NHL. The patients with an IB NHL tended to be older and presented more often with stage I or II and one extranodal site than patients with a CB and CB-Poly NHL. None of the subtypes showed a clear preference for localization in a particular site. The patients with IB or CB-Poly NHL showed a significantly worse prognosis than patients with CB NHL, with a 5-year overall survival for patients with CB NHL of 56.3% and for patients with IB or CB-Poly NHL 39.1% and 41.6% respectively. The 5-year disease free survival was 53.2% for the patients with CB, 32% for the patients with CB-Poly and 26.9% for the patients with IB NHL. A multivariate analysis showed that histological subtyping was of prognostic significance independent of the International Prognostic Index. This finding merits further exploration in prospective studies in order to judge the value of subclassification of large B-cell NHL as a guideline in therapy choice. © 1999 Cancer Research Campaig
Recommended from our members
NSLS-II Beam Diagnostics Overview
A new 3rd generation light source (NSLS-II) is in the early stages of construction at Brookhaven National Laboratory. The NSLS-II facility will provide ultra high brightness and flux with exceptional beam stability. It presents several challenges for diagnostics and instrumentation, related to the extremely small emittance. In this paper, we present an overview of all planned instrumentation systems, results from research and development activities; and then focus on other challenging aspects
Trachoma Prevalence and Associated Risk Factors in The Gambia and Tanzania: Baseline Results of a Cluster Randomised Controlled Trial
Trachoma is caused by Chlamydia trachomatis and is the leading infectious cause of blindness. The World Health Organization's (WHO) control strategy includes antibiotic treatment of all community members, facial cleanliness, and environmental improvements. By determining how prevalent trachoma is, decisions can be made whether control activities need to be put in place. Knowing what factors make people more at risk of having trachoma can help target trachoma control efforts to those most at risk. We looked at the prevalence of active trachoma and C. trachomatis infection in the eyes of children aged 0–5 years in The Gambia and Tanzania. We also measured risk factors associated with having active trachoma or infection. The prevalence of both active trachoma and infection was lower in The Gambia (6.7% and 0.8%, respectively) than in Tanzania (32.3% and 21.9%, respectively). Risk factors for active trachoma were similar in the two countries. For infection, the risk factors in Tanzania were similar to those for TF, whereas in The Gambia, only ocular discharge was associated with infection. These results show that although the prevalence of active trachoma and infection is very different between the two countries, the risk factors for active trachoma are similar but those for infection are different
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
The administration of endocrine therapy for 5 years substantially reduces recurrence rates during and after treatment in women with early-stage, estrogen-receptor (ER)-positive breast cancer. Extending such therapy beyond 5 years offers further protection but has additional side effects. Obtaining data on the absolute risk of subsequent distant recurrence if therapy stops at 5 years could help determine whether to extend treatment
- …